Deepbridge Capital
Award-winning Deepbridge provides investment opportunities into portfolios of actively-managed, growth-focused technology and life sciences companies, taking advantage of the potential tax benefits available under the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS).
We invest in a diverse range of sectors, including; FinTech, automotive tech, sustainable tech, drug discovery, therapeutics, healthcare tech, medtech, AI, VR/AR, Blockchain, space tech, biotech, Agritech and more.
Dealflow is sourced from numerous partners and contacts, with spinouts from 17 different universities within the portfolio.
At Deepbridge, our main priority is to always act in the best interest of our investors. We believe the best way of doing this is by taking a hands-on approach with our investee companies. We take an active role (not just a Board seat) to guide, mentor and counsel investee management teams.
The provision of hands-on operational experience, combined with financial expertise can materially mitigate the investment risk borne by the investor, along with comprehensive due diligence on investee companies.
Our ambition is to help investee companies achieve their full potential and thereby provide the best possible outcome for our investors.